Nuclear Medicine: Page 362

Therapeutic radiopharmaceutical market poised for takeoff
By AuntMinnie.com staff writers
Although U.S. sales of therapeutic radiopharmaceuticals totaled just $57 million in 2005, rapid growth is anticipated over the next five to six years. By 2012, therapeutic radiopharmaceutical product sales should reach $1.9 billion, with high growth continuing beyond that time, according to a recent study by market research firm Bio-Tech Systems.
February 20, 2006
Digirad posts flat revenues, loss in 2005
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad reported fourth-quarter revenues of $17.4 million, down 2.2% compared with the $17.8 million posted in the fourth quarter last year. For the period (end-December 31), the Poway, CA-based firm had a net loss of $2.8 million, compared with net income of $22,000 last year.
February 16, 2006
MDS Nordion, Molecular Insight Pharmaceuticals partner
By AuntMinnie.com staff writers
Radioisotope developer MDS Nordion and Molecular Insight Pharmaceuticals have signed a six-year renewable contract to manufacture and supply Zemiva, a molecular imaging pharmaceutical being developed for cardiac ischemia.
February 15, 2006
Imagin taps Oliverio
By AuntMinnie.com staff writers
PET and PET/CT imaging center developer Imagin Molecular has appointed Positron president Joseph Oliverio as CEO.
February 14, 2006
Positron opens Chinese joint venture
By AuntMinnie.com staff writers
PET vendor Positron of Houston has officially launched its joint venture with Neusoft Medical Systems of China.
February 12, 2006
Draxis shows 2005 revenue growth
By AuntMinnie.com staff writers
Canadian radiopharmaceutical developer Draxis Health reported solid gains in revenues and a slight dip in net income for its 2005 fiscal year (end-December 31).
February 9, 2006
Digirad partners with Ultrascan
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad has signed a personal services and management agreement with mobile ultrasound services provider Ultrascan of Suwanee, GA.
February 8, 2006
SPECT/CT helps clarify ambiguous bone foci
By Jonathan S. Batchelor
Bone scintigraphy with SPECT has a good track record for detecting metastatic areas with a high lesion-to-background contrast. But a drawback of SPECT has been that anatomic details can be lacking. Researchers from Germany, however, have found that SPECT/CT can increase specificity in cases when SPECT alone is equivocal.
February 8, 2006
IsoRay adds medical advisor
Medical isotope developer IsoRay Medical has appointed Dr. Steven Kurtzman as medical advisor.
January 31, 2006
GE launches Ventri cardiac gamma camera
By AuntMinnie.com staff writers
Multimodality vendor GE Healthcare of Chalfont St. Giles, U.K., is launching a new dual-head gamma camera targeted at the nuclear cardiology market.
January 31, 2006
Scintigraphy shows breast cancer response to hormone therapy sooner
By Shalmali Pal
Only a third of breast cancer patients who have endocrine therapy respond to treatment, and the current tests for patient selection are less than optimal. Some imaging techniques may not show results for several months post-treatment. Scintigraphy could be a better, noninvasive way to predict treatment response, according to European researchers.
January 25, 2006
2006 01 25 15 53 01 706
CardiArc receives FDA nod for SPECT unit
By AuntMinnie.com staff writers
Cardiac imaging device developer CardiArc has received Food and Drug Administration 510(k) clearance for its cardiac SPECT gamma camera.
January 24, 2006
Previous Page
Page 362 of 439
Next Page